Title : Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.

Pub. Date : 2010 Oct

PMID : 20600887






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 When targeted via RGD to tumor-cell-surface and tumor neovasculature endothelial cell receptors, cationic liposomes could specifically deliver siRNAs to tumor cells and thus reverse drug resistance by down-regulation of P-gp, following administration of targeted liposomes containing DOX that inhibit formerly drug-resistant tumors. Doxorubicin phosphoglycolate phosphatase Mus musculus
2 From the current results, the combination use of DOX and P-gp targeted siRNA showed significantly higher in vitro cytotoxicity in tumor cells than liposomal DOX alone. Doxorubicin phosphoglycolate phosphatase Mus musculus